Plutus Capital Management Acquires 7.75% Stake in Ganga Pharmaceuticals Through Warrant Conversion
Plutus Capital Management LLP has acquired a 7.75% stake in Ganga Pharmaceuticals through warrant conversion. The non-promoter entity acquired 3,75,000 shares via preferential allotment on July 17, 2025. This acquisition increased Ganga Pharmaceuticals' equity share capital from Rs. 4,83,65,000 to Rs. 5,91,15,000. Plutus Capital made the necessary disclosures under SEBI regulations on July 31, 2025.